Oxybutynin
8 NDCs across 2 manufacturers|5 Generic,3 Brand
Oxybutynin is used to treat dysuria, neurogenic urinary bladder and urinary incontinence, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 26, 2003, and the first generic was approved Mar 4, 2014. In 2024, Medicare Part D spent $1 million on Oxybutynin across 1,434 claims for 425 beneficiaries.
Oxybutynin is available as 8 NDCs from 2 manufacturers (5 generic, 3 brand), with NADAC prices from $0.08 to $81.29 per EA — the most expensive product costs about 966× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
8
5G / 3B
Manufacturers
2
competing in market
Price Spread
$0.08 – $81.29
per EA
7d Activity
avg +1.1% WoW · of 8 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Cholinergic Muscarinic Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing OXYBUTYNIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
OXYTROL 3.9 MG/24HR PATCH | $81.2854 per EA | -0.25% |
OXYTROL FOR WOMEN 3.9 MG/24HR | $2.7424 per EA | -0.26% |
OXYTROL FOR WOMEN 3.9 MG/24HR | $2.7424 per EA | -0.26% |
OXYBUTYNIN CL ER 15 MG TABLET | $0.1250 per EA | -0.20% |
OXYBUTYNIN CL ER 10 MG TABLET | $0.0997 per EA | +1.93% |
OXYBUTYNIN CL ER 10 MG TABLET | $0.0997 per EA | +1.93% |
OXYBUTYNIN CL ER 5 MG TABLET | $0.0841 per EA | +3.04% |
OXYBUTYNIN CL ER 5 MG TABLET | $0.0841 per EA | +3.04% |
Frequently Asked Questions
What is Oxybutynin used to treat?
Oxybutynin is used to treat dysuria, neurogenic urinary bladder and urinary incontinence, per the National Library of Medicine's MED-RT classification.
When did Oxybutynin become available as a generic?
FDA approved the first generic Oxybutynin (ANDA) on Mar 4, 2014.
How much does Medicare spend on Oxybutynin?
In 2024, Medicare Part D spent $1 million on Oxybutynin across 1,434 claims for 425 beneficiaries.
How many Oxybutynin products are on the market?
The Oxybutynin drug market contains 8 NDCs from 2 manufacturers — 5 generic and 3 brand products.
What is the price range for Oxybutynin?
NADAC reference prices for Oxybutynin range from $0.0841 to $81.2854 per EA — the most expensive product costs about 966× the cheapest.
Is generic Oxybutynin cheaper than brand?
The average generic NADAC for Oxybutynin is $0.0985 per EA, versus $28.9234 for brand-labeled products — brand versions average about 293× the generic price.
Which manufacturers make Oxybutynin?
2 manufacturers list Oxybutynin in NADAC. Ranked by number of NDCs, the largest are Zydus Pharmaceuticals (USA) Inc. (5), Allergan, Inc. (3).
How has the price of Oxybutynin changed recently?
Over the past 7 days, 4 Oxybutynin NDCs rose and 4 fell, with a market-wide average change of +1.1%.